Company Genomic Vision
Equities
GV
FR0011799907
Biotechnology & Medical Research
Business Summary
- sales of equipment and consumables: to academic laboratory centers using the molecular combing technology for research purposes;
- license and royalties income: income from collaboration with Quest Diagnostics;
- sales of software, testing kits and related consumables.
Number of employees: 33
Managers
Managers | Title | Age | Since |
---|---|---|---|
Aaron Bensimon
CEO | Chief Executive Officer | - | 04-06-10 |
Lionel Seltz
DFI | Director of Finance/CFO | - | 22-07-31 |
Thierry Huet
CTO | Chief Tech/Sci/R&D Officer | - | 21-10-12 |
Corporate Officer/Principal | - | 22-07-10 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Mohammed Afshar
BRD | Director/Board Member | - | 22-07-10 |
Aaron Bensimon
CEO | Chief Executive Officer | - | 04-06-10 |
Florence Alouch
CHM | Chairman | - | 22-07-10 |
Eric J. Edery
BRD | Director/Board Member | - | 22-07-10 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 385,886,117 | 377,646,318 ( 97.86 %) | 780,120 ( 0.2022 %) | 97.86 % |
Company contact information
Génomic Vision SA
Green Square Batiment E 80-84, rue des Meuniers
92220, Bagneux
+
http://www.genomicvision.com![address Genomic Vision(GV)](https://cdn.zonebourse.com/static/address/16068911.png)
Sector
1st Jan change | Capi. | |
---|---|---|
+49.41% | 57.87B | |
+41.65% | 40.25B | |
-6.72% | 39.94B | |
-5.96% | 28.54B | |
+12.99% | 26.4B | |
-19.82% | 19.33B | |
+32.35% | 12.4B | |
-0.08% | 12.23B | |
+25.18% | 12.2B |